Literature DB >> 10741951

A canine model of multiple portosystemic shunting.

L M Howe1, H W Boothe, M W Miller, D M Boothe.   

Abstract

The objective of this study was to develop and describe an experimental canine model of multiple acquired portosystemic shunts (PSS) similar in nature to spontaneously occurring PSS. Sixteen dogs were used and were divided into a control (n = 6) and a diseased group (n = 10). Dogs of the diseased group were administered dimethylnitrosamine (2 mg/kg of body weight, po) twice weekly, and clinicopathologic, ultrasonographic, and hepatic scintigraphic findings were recorded during the development of hepatic disease and PSS. Surgery was then performed to permit visual verification of multiple shunts, catheter placement for portography examination, and biopsy of the liver. All diseased dogs developed severe hepatic disease and multiple PSS as documented visually at surgery and on portography. Based on this study, dimethylnitrosamine-induced portosystemic shunting appears to be an appropriate model for spontaneously occurring multiple PSS secondary to portal hypertension.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10741951     DOI: 10.1080/089419300272258

Source DB:  PubMed          Journal:  J Invest Surg        ISSN: 0894-1939            Impact factor:   2.533


  3 in total

1.  Acute portal hypertension models in dogs: low- and high-flow approaches.

Authors:  Jaydev K Dave; Ji-Bin Liu; Valgerdur G Halldorsdottir; John R Eisenbrey; Daniel A Merton; Priscilla Machado; Hongjia Zhao; Joseph Altemus; Laurence Needleman; Daniel B Brown; Flemming Forsberg
Journal:  Comp Med       Date:  2012-10       Impact factor: 0.982

2.  A canine liver fibrosis model to develop a therapy for liver cirrhosis using cultured bone marrow-derived cells.

Authors:  Takashi Matsuda; Taro Takami; Ryo Sasaki; Tatsuro Nishimura; Yuki Aibe; Bruno Diaz Paredes; Luiz Fernando Quintanilha; Toshihiko Matsumoto; Tsuyoshi Ishikawa; Naoki Yamamoto; Kenji Tani; Shuji Terai; Yasuho Taura; Isao Sakaida
Journal:  Hepatol Commun       Date:  2017-07-17

3.  Increased canine pancreatic lipase immunoreactivity (cPLI) and 1,2-o-dilauryl-rac-glycero-3-glutaric acid-(6'-methylresorufin) ester (DGGR) lipase in dogs with evidence of portal hypertension and normal pancreatic histology: a pilot study.

Authors:  Gonçalo Serrano; Dominique Paepe; Tim Williams; Penny Watson
Journal:  J Vet Diagn Invest       Date:  2021-04-02       Impact factor: 1.279

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.